Trends and age-period-cohort effect on incidence of hepatitis B from 2008 to 2022 in Guangzhou, China
- PMID: 38862511
- PMCID: PMC11166960
- DOI: 10.1038/s41598-024-63796-0
Trends and age-period-cohort effect on incidence of hepatitis B from 2008 to 2022 in Guangzhou, China
Abstract
Hepatitis B virus (HBV) infection is highly prevalent in Guangzhou, China. This study aimed to examine the long-term trend of HB incidence from 2008 to 2022 and the independent impacts of age, period, and cohort on the trends. HBV data were collected from the China Information System for Disease Control and Prevention. Joinpoint regression was utilized to examine temporal trends, and an age-period-cohort model was employed to estimate the effects of age, period, and cohort. A total of 327,585 HBV cases were included in this study. The incidence of chronic and acute HB showed a decreasing trend in Guangzhou over the past 15 years, with an average annual percent change of - 4.31% and - 16.87%, respectively. Age, period, and cohort all exerted significant effects. The incidence of HB was higher in males than in females and non-central areas compared to central areas. Age groups of 0-4 years and 15-24 years were identified as high-risk groups. The period relative risks for chronic HB incidence decreased initially and then stabilized. Cohorts born later had lower risks. Chronic HB incidences remain high in Guangzhou, especially among males, younger individuals, and residents of non-central areas. More efforts are still needed to achieve hepatitis elimination targets.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Epidemic Trends and Spatial Distribution Characteristics of Hepatitis B in China: Surveillance Study.JMIR Public Health Surveill. 2025 May 12;11:e70888. doi: 10.2196/70888. JMIR Public Health Surveill. 2025. PMID: 40354628 Free PMC article.
-
Age-Period-Cohort Analysis on the Time Trend of Hepatitis B Incidence in Four Prefectures of Southern Xinjiang, China from 2005 to 2017.Int J Environ Res Public Health. 2019 Oct 14;16(20):3886. doi: 10.3390/ijerph16203886. Int J Environ Res Public Health. 2019. PMID: 31615013 Free PMC article.
-
Trends and age-period-cohort effect on incidence of brucellosis from 2006 to 2020 in China.Acta Trop. 2024 Dec;260:107475. doi: 10.1016/j.actatropica.2024.107475. Epub 2024 Nov 30. Acta Trop. 2024. PMID: 39622308
-
[Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Apr 6;52(4):402-408. doi: 10.3760/cma.j.issn.0253-9624.2018.04.013. Zhonghua Yu Fang Yi Xue Za Zhi. 2018. PMID: 29614608 Chinese.
-
Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.J Infect Public Health. 2020 Feb;13(2):221-227. doi: 10.1016/j.jiph.2019.08.004. Epub 2019 Aug 21. J Infect Public Health. 2020. PMID: 31445879 Review.
Cited by
-
Hepatitis B Hospitalizations in Brazil: Temporal and Regional Patterns from 2008 to 2023.Viruses. 2025 Feb 28;17(3):348. doi: 10.3390/v17030348. Viruses. 2025. PMID: 40143280 Free PMC article.
-
Epidemic Trends and Spatial Distribution Characteristics of Hepatitis B in China: Surveillance Study.JMIR Public Health Surveill. 2025 May 12;11:e70888. doi: 10.2196/70888. JMIR Public Health Surveill. 2025. PMID: 40354628 Free PMC article.
References
-
- World Health Organization. Hepatitis B. 2023. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 19 July 2023.
-
- World Health Organization. 2016. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. https://www.who.int/publications/i/item/WHO-HIV-2016.06. Accessed 19 July 2023.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous